Clinical Trial Update: Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance [NA]

View source ↗

Summary

This completed clinical trial evaluates whether chromium picolinate reduces the severity of acanthosis nigricans in adolescents with insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acanthosis Nigricans
• Insulin Resistance

Drugs mentioned

• Chromium Picolinate (chromium picolinate)

Snippet

Sponsor: Uruk University | Conditions: Insulin Resistance, Acanthosis Nigricans | NA | Status: COMPLETED